Glenn D Braunstein

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi request reprint Clinical practice. Gynecomastia
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    N Engl J Med 357:1229-37. 2007
  2. ncbi request reprint Androgen insufficiency in women
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, The David Geffen School of Medicine at UCLA, Room 2119 Plaza Level, North Tower, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Growth Horm IGF Res 16:S109-17. 2006
  3. doi request reprint The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008
    Wendy Sacks
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90403, USA
    Thyroid 20:1235-45. 2010
  4. ncbi request reprint Androgen insufficiency in women: summary of critical issues
    Glenn D Braunstein
    Cedars Sinai Medical Center UCLA School of Medicine, Los Angeles, California 90048, USA
    Fertil Steril 77:S94-9. 2002
  5. ncbi request reprint False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center University of California, Los Angeles, School of Medicine, 90048, USA
    Am J Obstet Gynecol 187:217-24. 2002
  6. pmc Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease
    Glenn D Braunstein
    Department of Medicine, Room 2119, Plaza Level, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048, USA
    J Clin Endocrinol Metab 93:4268-75. 2008
  7. ncbi request reprint The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Room 2119, Los Angeles, California 90048, USA
    J Clin Endocrinol Metab 92:4091-3. 2007
  8. ncbi request reprint Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    J Sex Med 4:859-66. 2007
  9. ncbi request reprint Safety of testosterone treatment in postmenopausal women
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, California 90048, USA
    Fertil Steril 88:1-17. 2007
  10. doi request reprint Testosterone reference ranges in normally cycling healthy premenopausal women
    Glenn D Braunstein
    Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    J Sex Med 8:2924-34. 2011

Collaborators

Detail Information

Publications42

  1. ncbi request reprint Clinical practice. Gynecomastia
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    N Engl J Med 357:1229-37. 2007
  2. ncbi request reprint Androgen insufficiency in women
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, The David Geffen School of Medicine at UCLA, Room 2119 Plaza Level, North Tower, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Growth Horm IGF Res 16:S109-17. 2006
    ..At present, no testosterone preparation has been approved by the FDA for the treatment of low sexual desire (HSDD), so all such therapy is considered to be off-label use at this time...
  3. doi request reprint The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008
    Wendy Sacks
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90403, USA
    Thyroid 20:1235-45. 2010
    ....
  4. ncbi request reprint Androgen insufficiency in women: summary of critical issues
    Glenn D Braunstein
    Cedars Sinai Medical Center UCLA School of Medicine, Los Angeles, California 90048, USA
    Fertil Steril 77:S94-9. 2002
    ..Androgen replacement therapy should be given the same consideration that we give estrogen replacement therapy...
  5. ncbi request reprint False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center University of California, Los Angeles, School of Medicine, 90048, USA
    Am J Obstet Gynecol 187:217-24. 2002
    ..An algorithm is presented to aid in the recognition of false-positive human chorionic gonadotropin results in patients...
  6. pmc Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease
    Glenn D Braunstein
    Department of Medicine, Room 2119, Plaza Level, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048, USA
    J Clin Endocrinol Metab 93:4268-75. 2008
    ..If so, then epidemiologic studies that examine the association between androgens and pathological processes should adjust the results for the independent effect of estrogens...
  7. ncbi request reprint The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Room 2119, Los Angeles, California 90048, USA
    J Clin Endocrinol Metab 92:4091-3. 2007
  8. ncbi request reprint Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    J Sex Med 4:859-66. 2007
    ..Although only short-term data exist on safety from the double-blind, placebo-controlled trials, testosterone has been used for more than 50 years. Therefore, some data concerning the long-term safety issues must exist in the literature...
  9. ncbi request reprint Safety of testosterone treatment in postmenopausal women
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, California 90048, USA
    Fertil Steril 88:1-17. 2007
    ..To critically examine the safety of T therapy given to postmenopausal women...
  10. doi request reprint Testosterone reference ranges in normally cycling healthy premenopausal women
    Glenn D Braunstein
    Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    J Sex Med 8:2924-34. 2011
    ..At present, there are no well-accepted reference ranges for serum testosterone concentrations in women...
  11. pmc Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
    Chrisandra L Shufelt
    Division of Cardiology, Heart Institute and Department of Medicine, Cedars Sinai Medical Center, 444 S San Vicente Blvd, Los Angeles, CA 90048, USA
    Menopause 18:943-50. 2011
    ..The aim of this study was to assess the relationship of the timing of hormone therapy (HT) use with angiographic coronary artery disease (CAD) and cardiovascular disease (CVD) events in women with natural versus surgical menopause...
  12. pmc Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study)
    Bina Ahmed
    Department of Medicine, Division of Cardiology, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA
    Am J Cardiol 102:150-4. 2008
    ..The presence of both DM and HHE predicted a greater burden of angiographic CAD. Prospective research is warranted to better understand causal relations between DM, endogenous hormones, and MACE in premenopausal women...
  13. ncbi request reprint Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study
    C Noel Bairey Merz
    Division of Cardiology, Department of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA
    J Am Coll Cardiol 41:413-9. 2003
    ..We sought to evaluate hypoestrogenemia of hypothalamic origin and its association with angiographic coronary artery disease (CAD) in premenopausal women...
  14. pmc Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
    C Noel Bairey Merz
    Division of Cardiology, Department of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA
    J Womens Health (Larchmt) 18:1315-22. 2009
    ..The aim of this study was to evaluate the relationships between detailed measurements of endogenous and exogenous estrogen exposure time with angiographic CAD and major adverse cardiovascular events...
  15. pmc Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study
    Chrisandra Shufelt
    Women s Heart Center, The Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Womens Health (Larchmt) 21:281-4. 2012
    ..Aromatase inhibitors (AIs) prevent the conversion of androgens to estrogen and occur naturally in grapes, grape juice, and red, but not white wine. We tested whether red wine is a nutritional AI in premenopausal women...
  16. ncbi request reprint Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE)
    C Noel Bairey Merz
    Division of Cardiology, Department of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA
    Am J Med 113:723-7. 2002
    ..We also sought to evaluate this association, independent of statin use, particularly among premenopausal women of childbearing age...
  17. pmc Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome
    C Noel Bairey Merz
    1 Barbra Streisand Women s Heart Center, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California
    J Womens Health (Larchmt) 25:875-81. 2016
    ..Women with polycystic ovary syndrome (PCOS) have greater cardiac risk factor clustering but the link with mortality is incompletely described...
  18. pmc DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE)
    Chrisandra Shufelt
    Heart Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Clin Endocrinol Metab 95:4985-92. 2010
    ..Low levels have been associated with increased cardiovascular disease (CVD) risk and all-cause mortality, although these results have not been consistently replicated, particularly in women...
  19. pmc Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)
    Rebecca C Thurston
    1Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 2Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 3Barbra Streisand Women s Heart Center, Cedars Sinai Heart Institute, Los Angeles, CA 4Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Wake Forest School of Medicine, Winston Salem, NC 5Department of Obstetrics and Gynecology, Keck School of Medicine of University of Southern California, Los Angeles, CA 6Division of Cardiology, Department of Medicine, University of Florida, Gainesville, FL 7Division of Cardiovascular Disease, Department of Medicine, University of Alabama Birmingham, AL 8Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 9Division of Cardiology, Department of Medicine, Allegheny General Hospital, Pittsburgh, PA 10Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
    Menopause . 2016
    ..Data suggest that associations may depend upon the age that symptoms occur. We examined associations between VMS and cardiovascular events and endothelial function, considering age of symptom onset...
  20. pmc A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause
    Jeannette M Painovich
    Department of Medicine, Cedars Sinai Heart Institute, Los Angeles, CA 90048, USA
    Menopause 19:54-61. 2012
    ....
  21. pmc Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored W
    Leslee J Shaw
    Division of Cardiology, Department of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Clin Endocrinol Metab 93:1276-84. 2008
    ..Women with polycystic ovary syndrome (PCOS) have a greater clustering of cardiac risk factors. However, the link between PCOS and cardiovascular (CV) disease is incompletely described...
  22. ncbi request reprint The use of dehydroepiandrosterone therapy in clinical practice
    Deborah R Cameron
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Treat Endocrinol 4:95-114. 2005
    ....
  23. doi request reprint Safety of testosterone use in women
    Chrisandra L Shufelt
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Maturitas 63:63-6. 2009
    ..Nevertheless, only long-term safety studies will provide conclusive evidence as to testosterone safety in women...
  24. ncbi request reprint Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial
    Glenn D Braunstein
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, Calif, 90048, USA
    Arch Intern Med 165:1582-9. 2005
    ..Oophorectomy reduces serum testosterone levels. We studied the efficacy and safety of transdermal testosterone in treating hypoactive sexual desire disorder in surgically menopausal women...
  25. doi request reprint Testosterone and the breast
    Chrisandra L Shufelt
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Menopause Int 14:117-22. 2008
    ..High-dose androgen therapy also has been effective in treating patients with advanced breast cancer. Thus, the preponderance of data suggests that T use in females is not associated with an increased risk of breast carcinoma...
  26. doi request reprint Androgen deficiency and therapy in women
    Ruchi Mathur
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Curr Opin Endocrinol Diabetes Obes 17:342-9. 2010
    ..This review will provide a brief overview of androgen physiology, outline the conditions associated with androgen deficiency in women, and provide data on the potential benefits and risks of testosterone therapy...
  27. pmc Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft
    Manoj Garg
    Cancer Science Institute CSI of Singapore M G, D K, S V, A M T, L Z L, K T T, W J C, H Y, H P K, National University of Singapore, Singapore 117599, Singapore Division of Hematology Oncology R O, Q H, T A, S G, H P K, Cedars Sinai Medical Center, Los Angeles, California 90048 Graduate School of Medicine Y N, S O, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan Department of Medicine G D B, Cedars Sinai Medical Center, Los Angeles, California 90048 Department of Pathology and Laboratory Medicine J W S, N B D, David Geffen School of Medicine, Los Angeles, California 90048 and National University Cancer Institute H P K, National University Hospital, Singapore 117599
    J Clin Endocrinol Metab 100:725-35. 2015
    ..We established cell lines from a primary ATC and its lymph node metastasis, and investigated the molecular factors and genomic changes associated with tumor growth...
  28. doi request reprint Do patients gain weight after thyroidectomy for thyroid cancer?
    Joshua T Weinreb
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Thyroid 21:1339-42. 2011
    ....
  29. doi request reprint Pharmacologic treatment options for hypoactive sexual desire disorder
    Sheila Y Bolour
    Cedars Sinai Medical Center, David Geffen School of Medicine, UCLA, Los Angeles, California, USA
    Womens Health (Lond) 1:263-77. 2005
    ....
  30. ncbi request reprint Androgen replacement therapy in women
    Deborah R Cameron
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Fertil Steril 82:273-89. 2004
    ..Review of literature with regard to androgen replacement therapy in women...
  31. doi request reprint Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer
    Wendy Sacks
    1 Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California
    Thyroid 25:377-85. 2015
    ..In addition, we compared RAI treatment rates for DTC at CSMC to data from the National Cancer Database (NCDB) to see if the trends in RAI use at CSMC differed from the national trends...
  32. doi request reprint Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma
    Ronnie Meiyi Wong
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Thyroid 23:566-74. 2013
    ..Several staging systems exist to estimate the prognosis for patients with thyroid carcinoma. Our goal was to develop a new staging system to predict cancer-specific survival (CSS) and evaluate it against published systems...
  33. doi request reprint Drug-induced gynecomastia: an evidence-based review
    Fnu Deepinder
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Expert Opin Drug Saf 11:779-95. 2012
    ..However, these reports suffer from a multitude of deficiencies, including poor quality of evidence...
  34. doi request reprint Do faculty intensivists have better outcomes when caring for patients directly in a closed ICU versus consulting in an open ICU?
    Dani Hackner
    Pulmonary Critical Care Medicine Division, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Hosp Pract (1995) 37:40-50. 2009
    ....
  35. ncbi request reprint Update on subclinical hyperthyroidism
    Ines Donangelo
    Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Am Fam Physician 83:933-8. 2011
    ..Prospective randomized controlled trials are needed to address the effects of early treatment on potential morbidities to help determine whether screening should be recommended in the asymptomatic general population...
  36. pmc Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR
    Manoj Garg
    Cancer Science Institute of Singapore M G, D K, S J, V M, W C, A s, LW D, M X, L Z L, H Y, H P K, National University of Singapore, and National University Cancer Institute H P K, National University Hospital, 117599 Singapore Division of Hematology Oncology R O, S G, H P K, Cedars Sinai Medical Center, and Departments of Pathology and Laboratory Medicine J W S, N B D, Medicine G D B, David Geffen School of Medicine, University of California School of Medicine, Los Angeles, California 90059
    J Clin Endocrinol Metab 99:E62-72. 2014
    ..Laminin subunit-γ-2 (LAMC2) is an epithelial basement membrane protein involved in cell migration and tumor invasion and might represent an ideal target for the development of novel therapeutic approaches for ATC...
  37. pmc Early recognition of risk factors for adverse outcomes during hospitalization among Medicare patients: a prospective cohort study
    Jeff Borenstein
    Applied Health Services Research, Cedars Sinai Health System, Los Angeles, CA 90048, USA
    BMC Geriatr 13:72. 2013
    ..We sought to identify patient characteristics associated with adverse events that are present early in a hospital stay...
  38. ncbi request reprint Dermatologic manifestations of hypopituitarism
    Jordan L Geller
    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Clin Dermatol 24:266-75. 2006
    ..We describe the causes and presentation of hypopituitarism with an emphasis on its dermatologic manifestations...
  39. ncbi request reprint Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study
    Marian B Olson
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Womens Health (Larchmt) 15:836-42. 2006
    ..The purpose of this study was to evaluate body mass index (BMI) and waist circumference and the association of obesity distribution with blood estrogen levels (estradiol, bioavailable estradiol, and estrone)...
  40. ncbi request reprint Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
    B Delia Johnson
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    J Womens Health (Larchmt) 13:872-87. 2004
    ....
  41. ncbi request reprint Bisphosphonate therapy in primary hyperparathyroidism
    Jerome M Hershman
    J Bone Miner Res 18:1889; author reply 1890. 2003
  42. ncbi request reprint Editorial comment: unraveling the cause of HIV-related gynecomastia
    Glenn D Braunstein
    AIDS Read 14:38-9. 2004